IGF2BP3 and cancer: IGF2BP3 sustains the cellular levels of acetyl-CoA by directly binding to lncRNA TINCR and preventing its degradation, which blocks the ubiquitin-mediated degradation of ATP citrate lyase to promote lipid biosynthesis and induces cancer progression and chemoresistance 71.